Skip to content
Peptide research

Thymosin Beta-4

Also known as TB4 · Tβ4
Category
Tissue Repair & Recovery
Administration routes
Injectable
Regulatory status
Not FDA-approved

What it is

A 43-amino-acid peptide, sold mostly as the synthetic fragment TB-500 and marketed for wound healing and tendon and muscle repair. The case rests almost entirely on animal and mechanism work, so the human benefit case is weak. It promotes blood-vessel growth and cell migration, leaving a theoretical tumor concern unresolved and long-term safety unestablished. Not an approved US drug; most supply consists of unregulated products sold online, of uncertain purity.

Read Full record

Studied uses & evidence

Studied uses(6)

  • Accelerated wound healing with increased reepithelialization (42-61% improvement)

    Low

    The 42-61% figure comes from a 1999 rat wound model; human skin trials missed their goals.

  • Reduced scar formation and fibrosis through decreased myofibroblast activity

    Low

    Consistent animal and lab data show fewer scar-forming cells; no human anti-fibrosis trials yet.

  • Promoted corneal wound healing and reduced inflammation in eye injury models

    Medium

    Extensive animal data plus human eye trials, though pivotal trials showed only trends or missed goals.

Evidence limits

Evidence Level
Moderate Evidence (Strong Preclinical, Limited Human)

Thymosin Beta-4 has exceptionally strong preclinical evidence across dermal, corneal, cardiac, and neurological injury models. Human clinical trials are more limited. RGN-259 reached Phase 3 trials in neurotrophic keratopathy and dry eye; encouraging secondary and subgroup findings have not established efficacy, and the dry-eye trials missed their prespecified coprimary endpoints. Topical Tb4 has been tested in small human wound healing studies showing accelerated healing. Cardiac applications remain in preclinical stages. The full 43-amino-acid protein has a substantially larger evidence base than the TB-500 fragment.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Active cancer

    High

    Promotes cell migration, angiogenesis, and tissue remodeling — same concerns as TB-500 (its active fragment).

General cautions

  • Pregnancy

    Absolute

    No reproductive safety data.

Risk summary(3)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Long-term human safety not established

    Moderate
  • Promotes angiogenesis/cell migration; theoretical tumor concern

    Moderate
  • Mild injection site reactions when given subcutaneously

    Low
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.